BioCentury
ARTICLE | Deals

In-depth M&A analysis in a new BioCentury format: Letter from the Editor

June 19, 2020 12:33 AM UTC

Last week, we introduced the latest addition to the ways we provide insight, a presentation format that provides a simple interface for delivering in-depth data analysis.

It’s part of a drive to dispatch intelligence that can be digested quickly by busy biopharma executives and investors -- a need that has become more urgent with the pace at which events are unfolding this year...